Structure-activity mapping of ARHGAP36 reveals regulatory roles for its GAP homology and C-terminal domains
ARHGAP36 is an atypical Rho GTPase-activating protein (GAP) family member that drives both spinal cord development and tumorigenesis, acting in part through an N-terminal motif that suppresses protein kinase A and activates Gli transcription factors. ARHGAP36 also contains isoform-specific N-termina...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Dataset |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ARHGAP36 is an atypical Rho GTPase-activating protein (GAP) family member
that drives both spinal cord development and tumorigenesis, acting in part
through an N-terminal motif that suppresses protein kinase A and activates
Gli transcription factors. ARHGAP36 also contains isoform-specific
N-terminal sequences, a central GAP-like module, and a unique C-terminal
domain, and the functions of these regions remain unknown. Here we have
mapped the ARHGAP36 structure-activity landscape using a deep
sequencing-based mutagenesis screen and truncation mutant analyses. Using
this approach, we have discovered several residues in the GAP homology
domain that are essential for Gli activation and a role for the C-terminal
domain in counteracting an N-terminal autoinhibitory motif that is present
in certain ARHGAP36 isoforms. In addition, each of these sites modulates
ARHGAP36 recruitment to the plasma membrane or primary cilium. Through
comparative proteomics, we also have identified proteins that
preferentially interact with active ARHGAP36, and we demonstrate that one
binding partner, prolyl oligopeptidase-like protein, is a novel ARHGAP36
antagonist. Our work reveals multiple modes of ARHGAP36 regulation and
establishes an experimental framework that can be applied towards other
signaling proteins. |
---|---|
DOI: | 10.5061/dryad.dz08kprv9 |